Physician

Brian Reilly Langford, M.D.

According to 2025 Medicare claims, Brian Langford, M.D. (NPI: 1891051827) practices otolaryngology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is HEATON EAR NOSE AND THROAT ASSOCIATES OF EAST TEXAS P A (NPI: 1306988035; TIN: 751988042) and primary practice location at 75605-8167.

Langford's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 695 traditional Medicare patients, billed 5,414 HCPCS/CPT codes, and received $354,666 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 914 prescription claims across 309 beneficiaries totaling $58,465 in drug costs, led by Azelastine Hcl (Azelastine Hcl). DME data shows 20 claims. Open Payments data shows 12 records totaling $488. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,498 to $354,666. Similarly, Part D prescription costs have moved sharply higher in recent years, from $7,670 to $58,465. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	73	153	$12,498
2018	124	363	$33,261
2019	228	762	$48,732
2020	335	1,720	$100,103
2021	399	3,231	$156,570
2022	404	3,168	$171,153
2023	592	4,683	$268,968
2024	695	5,414	$354,666

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	75	144	$7,670
2016	66	121	$4,546
2017	49	85	$2,632
2018	42	116	$3,544
2019	102	234	$5,508
2020	158	401	$14,823
2021	254	648	$25,132
2022	242	634	$20,631
2023	278	715	$39,634
2024	309	914	$58,465

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	15	$718
2024	N/R	20	$727

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	196	256	$135
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	274	274	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	305	648	$88
92557	Comprehensive hearing and speech recognition test	202	214	$24
92567	Test to assess middle ear function	178	189	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Azelastine Hcl	Azelastine Hcl	127	5,680	$4,224
Ipratropium Bromide	Ipratropium Bromide	138	4,536	$3,333
Epinephrine	Epinephrine	18	561	$2,910
Fluticasone Propionate	Fluticasone Propionate	97	4,915	$1,382
Nortriptyline Hcl	Nortriptyline Hcl	81	2,395	$928

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	20	$727

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$488	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Reilly Langford, M.D.?

Tedicare shows public-source Medicare data for Brian Reilly Langford, M.D. (NPI 1891051827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Reilly Langford, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Reilly Langford, M.D.?

Brian Reilly Langford, M.D. is linked to HEATON EAR NOSE AND THROAT ASSOCIATES OF EAST TEXAS P A (billing NPI 1306988035) in the available physician profile data.

Does Brian Reilly Langford, M.D. have Open Payments data?

Brian Reilly Langford, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.